Study to Evaluate the Effects of AZD3427 in Patients With Heart Failure

Summary

The primary purpose of this mechanistic study is to evaluate the vasodilatory effects of AZD3427 in adult patients with heart failure and will be performed at approximately 2 study sites in the United Kingdom.

Timeline

Start

2021-11-23

Primary completion

2022-08-02

Completion

2022-08-02

Outcome

Outcome not reported

Stopped (Enrollment): “Study start up timelines delayed into late autumn, and with COVID cases rising in the UK, the feasibility of successfully recruiting the study and ethical concerns about starting a study that AZ may not be able to complete.”

Drugs

Indications